an official application for the creation of a European biocluster
The headquarters of Lyonbiopôle. Credit: Google Street View
As part of the France 2030 investment plan, the Auvergne-Rhône-Alpes region and regional players in infectious diseases submitted an official application in July for the creation of a European biocluster in immuno-infectiology in Lyon.
It had been in the cards for several months and it is now official: an official application has been submitted for the creation of a European biocluster in Lyon. It is the Auvergne-Rhône-Alpes region, the metropolises of Lyon and Grenoble and the Lyonbiopôle, with regional players in infectious diseases, who are behind this application.
It would be one of the three bioclusters developed in France. A biocluster centered on oncology has already opened in Saclay in Essonne. In the form of a campus in the Gerland biodistrict, the central ambition of the future Lyon biocluster would be to create an ecosystem of excellence in immuno-infectiology which will make it possible to prepare the fight against the infectious diseases of tomorrow.
The teams at this research site would focus their efforts on major public health issues: emerging and re-emerging viruses, respiratory diseases and antibiotic resistance.
“Emerging infectious diseases and resistance to susceptible are public health challenges”
Bruno Lina, future president of the biocluster
One of the driving forces behind this project is the grouping together of major players involved in infectious diseases: major hospitals (HCL, AP-HP Saint Etienne, etc.), academic institutions (Claude Bernard Lyon 1 University, Paris Cité University , INSERM-ANRS-MIE, Institut Pasteur, etc.), specialized industrial players (Biomérieux, Sanofi, Boehringer Ingelheim) and the fabric of SMEs announced in the region that work in the fields of infectious diseases in human and animal health.
“Emerging infectious diseases and resistance to susceptible are health challenges which provides for rapid responses intended to manage the short term, as well as the longer term. Achieving these objectives requires combining the strengths of strong, inventive and multi-sector upstream research with an industrial response capacity combining the ambition of innovation and breakthrough”comments Bruno Lina, future president of the biocluster.